High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors

BACKGROUND: Recent identification of a specific role of HSF1 in cancer progression has led to new relevance of HSF1 as both a prognostic and a predictive marker. The role of HSF1 in endometrial cancer has so far been unexplored. METHODS: A total of 823 lesions from endometrial carcinoma precursors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Engerud, H, Tangen, I L, Berg, A, Kusonmano, K, Halle, M K, Øyan, A M, Kalland, K H, Stefansson, I, Trovik, J, Salvesen, H B, Krakstad, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090731/
https://www.ncbi.nlm.nih.gov/pubmed/24853175
http://dx.doi.org/10.1038/bjc.2014.262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090731/
https://www.ncbi.nlm.nih.gov/pubmed/24853175
http://dx.doi.org/10.1038/bjc.2014.262

Ejemplares similares